Altimmune, Inc. (ALT): Total Assets
$279.93M
As of 2025-12-31
$527.21M
As of 2026-06-30
+10.6%
3-year compound annual growth
+2.7%
5-year compound annual growth
+30.3%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $279.93M | +100.9% | 2026-03-06, Balance as of period end |
| 2024-12-31 | $139.31M | -33.9% | 2026-03-06, Balance as of period end |
| 2023-12-31 | $210.64M | +1.8% | 2025-02-27, Balance as of period end |
| 2022-12-31 | $206.93M | -5.5% | 2024-03-27, Balance as of period end |
| 2021-12-31 | $218.87M | -10.7% | 2023-02-28, Balance as of period end |
| 2020-12-31 | $245.12M | +353.4% | 2022-03-15, Balance as of period end |
| 2019-12-31 | $54.06M | -1.3% | 2021-02-25, Balance as of period end |
| 2018-12-31 | $54.75M | -13.1% | 2020-03-27, Balance as of period end |
| 2017-12-31 | $63.03M | +64.1% | 2019-04-01, Balance as of period end |
| 2016-12-31 | $38.40M | +93.3% | 2018-04-02, Balance as of period end |
| 2015-12-31 | $19.86M | -9.6% | 2017-03-14, Balance as of period end |
| 2014-12-31 | $21.98M | +28.2% | 2016-03-11, Balance as of period end |
| 2013-12-31 | $17.14M | -24.6% | 2015-03-11, Balance as of period end |
| 2012-12-31 | $22.74M | -0.3% | 2014-03-11, Balance as of period end |
| 2011-12-31 | $22.80M | -16.2% | 2013-03-14, Balance as of period end |
| 2010-12-31 | $27.20M | n/a | 2012-03-08, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Altimmune, Inc. (ALT) | 2025-12-31 | $279.93M | +100.9% |
| Neonc Technologies Holdings, Inc. (NTHI) | 2025-12-31 | $2.82M | -17.4% |
| Lyell Immunopharma, Inc. (LYEL) | 2025-12-31 | $340.05M | -30.7% |
| Lunai Bioworks Inc. (LNAI) | 2026-06-30 | $9.94M | +20.8% |
| Impact Biomedical Inc. (IBO) | 2025-12-31 | $17.41M | -14.2% |
| HCW Biologics Inc. (HCWB) | 2025-12-31 | $24.52M | -18.9% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $116.46M | -22.7% |
| Talphera, Inc. (TLPH) | 2025-12-31 | $29.72M | +63.0% |
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | $56.08M | -44.6% |
Compare ALT, NTHI, LYEL, LNAI side by side · Screen every company in Pharmaceutical Preparations ↗